share_log

Galapagos Bets €225M On CellPoint Marking Its Entry Into CAR-T Field

Galapagos Bets €225M On CellPoint Marking Its Entry Into CAR-T Field

加拉帕戈斯向CellPoint下注2.25亿欧元，标志着其进入CAR-T领域
Benzinga Real-time News ·  2022/06/22 06:40
  • Galapagos (NASDAQ:GLPG) agreed to acquire CellPoint and AboundBio in an all-cash transaction propelling into next-generation cell therapy while significantly broadening its portfolio and capabilities.
  • Galapagos will pay an upfront amount of €125 million for CellPoint, an additional €100 million to be paid upon achieving certain milestones, and $14 million for AboundBio. 
  • Galapagos said that, through the acquisition of CellPoint and AboundBio, it gains access to an automated point-of-care cell therapy supply model and a next-generation fully human antibody-based therapeutics platform.
  • Related: RBC Expects Business Development To Unlock This Pharma Stock's Balance Sheet Value.
  • The deal aims for three next-generation CAR-Ts to the clinic over the next three years.
  • CellPoint has developed a novel point-of-care supply model, which offers the potential for efficient, 7-day delivery of CAR-T therapies and avoids complex logistics. 
  • The proprietary platform consists of CellPoint's end-to-end xCellit workflow management and monitoring software and Lonza Group's (OTC:LZAGF) Cocoon system, a closed, automated manufacturing platform for cell and gene therapies.
  • Price Action: GLPG shares are down 1.91% at $54.93 during the premarket session on the last check Wednesday.
  • 加拉帕戈斯纳斯达克股票代码：GLPG）同意以全现金交易收购CellPoint和AboundBio，推动下一代细胞疗法，同时显著扩大其产品组合和能力。
  • 加拉帕戈斯将为CellPoint支付1.25亿欧元的预付款，在实现某些里程碑后额外支付1亿欧元，为AboundBio支付1400万美元的预付款。
  • 加拉帕戈斯表示，通过收购CellPoint和AboundBio，它获得了自动化即时细胞疗法供应模式和下一代完全基于人类抗体的治疗平台。
  • 相关： 加拿大皇家银行预计业务发展将释放这只制药股的资产负债表价值。
  • 该协议的目标是在未来三年内为该诊所提供三台下一代CAR-T。
  • CellPoint开发了一种新颖的即时医疗供应模式，该模式有可能在7天内高效交付CAR-T疗法，并避免了复杂的物流。
  • 专有平台由CellPoint的端到端xCellit工作流程管理和监控软件组成，以及龙沙集团的（OTC: LZAGF）Cocoon系统，一个用于细胞和基因疗法的封闭式自动化制造平台。
  • 价格走势：在周三的最后一张支票盘前交易中，GLPG股价下跌1.91％，至54.93美元。
声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发